1
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38269 | Purfalcamine | ||
Purfalcamine is an orally active, selective Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) inhibitor with an IC50 of 17 nM and an EC50 of 230 nM. Purfalcamine has antimalarial activity and causes malaria parasites developmental arrest at the schizont stage[1][2]. Purfalcamine has low activity against Toxoplasma gondii calcium-dependent protein kinase 3 (TgCDPK3)[1]. Purfalcamine (225, 450 nM) has no effect on the parasitemia in the first 32 hours. After about 40 hours, paras... |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-03000 |
ATase Protein, Mycobacterium tuberculosis, Recombinant (His)
ATase,Glutamine phosphoribosylpyrophosphate amidotransferase... |
Mycobacterium tuberculosis | E. coli |
Catalyzes the formation of phosphoribosylamine from phosphoribosylpyrophosphate (PRPP) and glutamine. ATase Protein, Mycobacterium tuberculosis, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 56.5 kDa and the accession number is P9WHQ6. |